期刊文献+

生物类似物研究领域的知识图谱分析及其对我国政策启示 被引量:2

Biosimilars Researches Based on a Scientometric Map Analysis and Its Political Implications
下载PDF
导出
摘要 本文将战略性新兴生物医药产业——生物类似物作为研究对象,在Web of Science的SCI数据库中以2004—2013年全球范围内该领域的研究论文做数据来源,通过信息可视化软件Cite Space II绘制知识图谱,了解生物类似物研究领域的基本状况、研究热点和前沿,提出现阶段我国生物类似物的发展与政策构建建议。 Through a visualized software CiteSpace II to draw scientometric maps, this paper focuses on the biosimilar researches in the bioedical industry, and analyzes the articles in the Web of Science database from 2004 to 2013, thereby understanding the basic situation, research hot topics and future development in biosimilar field. Finally, associated with current situations in China, this paper proposes specific policy construction strategies for upgrading the biosimilar development.
作者 陈名 邵蓉
出处 《中国科技论坛》 CSSCI 北大核心 2014年第11期144-148,共5页 Forum on Science and Technology in China
基金 国家社会科学基金"药品质量规制视角下的药品监管法实施效果研究"(11BFX098)
关键词 生物类似物 知识图谱 CITESPACE Ⅱ政策构建 Biosimilar Scientometric map CiteSpace Ⅱ Policy construction
  • 相关文献

参考文献15

  • 1Chen C. CiteSpace II:Detecting and Visualizing Emerging Trends and Transient Patterns in Scientific Literature[ J]. Journal of theAmerican Society for Information Science and Technology,2006,57(3) :359 -377.
  • 2Mellstedt H,Niederwieser D,Ludwig H. The Challenge of Biosimilars[ J] . Annals of oncology,2008,19(3) :411 -419.
  • 3Woodcock J,Griffin J,Behrman R,et al. The FDA’s Assessment of Follow - on Protein Products:a Historical Perspective[ J]. NatureReviews Drug Discovery, 2007 ,6(6) :437 -442.
  • 4Casadevall N,Nataf J,Viron B,et al. Pure Red - cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombi-nant Erythropoietin[ J]. New England Journal of Medicine,2002,346(7 ) :469 -475.
  • 5SchellekensH. Factors Influencing the Immunogenicity of Therapeutic Proteins[ J]. Nephrology Dialysis Transplantation,2005,20(suppl 6) : vi3 - vi9.
  • 6钱万强,陈涛,江海燕.基于文献计量学的国内外干细胞研究热点分析[J].中国科技论坛,2012(2):152-159. 被引量:9
  • 7Schellekens H. Biosimilar Epoetins:How Similar are They[ J] . Eur J Hosp Pharm,2004,3 :43 -7.
  • 8Roger S D. Biosimilars:How Similar or Dissimilar are They. ( Review Article) [ J]. Nephrology ,2006,11 (4) :341 - 346.
  • 9Schneider C K, Kalinke U. Toward Biosimilar Monoclonal Antibodies [ J ]. Nature Biotechnology, 2008,26 ( 9) :985 -990.
  • 10World Health Organization. Guidelines on Evaluation of Similar Biotherapeutic Products ( SBPs) [ J/OL]. (2014 -01 - 20) . ht-tp:// www. who. int/biologicals/areas/biological一therapeutics/BIOTHERAPEUTICS一FOR_WEB_22APRIL2010. pdf.

二级参考文献52

  • 1Avidor Y, Mabjeesh NJ,Matzkirl H.Bioteehnology and drug discovery: from bench to bedside[J].South Med J,2003,96( 12): 1174-1186.
  • 2European Parliament and Council.Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004[J].Off J Eur Union,2004,47:34-57.
  • 3European Medicines Agency, Guideline on similar biological medicinal products 2005[EB/OL]. http://www.tga.gov.au/DOCS/ pdf/euguide/chrnp/043704final.pdf,2005-10-30/2008-03-04.
  • 4US Food and Drug Administration.Omnitrope (somatropin [rDNA origin]) questions and answers 2006[EB/OL].http://www.fda.gov/ cder/drug/infopage/somatropin/qa.htm,2006-09-15/2008-03 -03.
  • 5Crommelin DJ,Bermejo T, Bissig M,et al.Pharmaceutical evaluation of biosimilars: important differences from generic low-molecular weight pharm[J].Eur J Hosp Pharm Sci,2005,11(1):11-17.
  • 6Roger SD.Biosimilars: how similar or dissimilar are they? [J]. Nephrology (Carlton),2006,11 (4):341-346.
  • 7Schellekens H.Manufacture and quality control of biophammeetaicals [J].Revista Espa'nola de Econom" la de la Salud,2008,6:340-344.
  • 8Locatelli F, Aljama P, Barany P, et al.Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure[J].Nephrol Dial Transplant,2004,19(Suppl 2):iil- ii47.
  • 9Kessler M,Goldsmith D, Schellekens H.Immtmogenicity ofbiopharmaceuticals[J].Nephrol Dial Transplant,2006,21(Suppl 5):v9-v12.
  • 10Smith N.EMEA 'will not guarantee' that biosimilars are interchangeable with originator[EB/OL], http://www, apmhealtheurope.com/story.php?depsPage=3&numero=3250,2006-07-21 / 2008-04-21.

共引文献17

同被引文献18

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部